Tag:FDA compliance
The Regulation of Cosmetics in the U.S.: Where It’s Been and Now Is Headed
The cosmetics industry in the U.S. has fallen behind in safety regulations compared to its European counterparts. The European Union has banned roughly 1,300 different ingredients in personal care products while the U.S. has banned merely 11. The last major update to regulations in the U.S. was in 2022 with the Modernization of Cosmetics Regulation Act (MoCRA). However, there is still work that needs to be done to address the health and safety risks that the cosmetic industry poses. The “Safer Beauty Bill Package” is just one proposed regulation that would majorly alter how personal care products are regulated in the U.S.
Eggflation: The Rising Cost of Eggs and Its Impact on Consumers
Egg prices are soaring, but is it just supply issues—or something more? While avian flu and regulations have strained production, major suppliers are raking in record profits, raising suspicions of price manipulation. A federal jury recently found top producers guilty of price-fixing, fueling concerns that consumers are being taken advantage of. As grocery bills climb, the question remains: who’s really cracking under pressure?
Navigating the Genetic Frontier: 23andMe and the Challenges of Data Security
A recent situation involving millions of 23andMe users has raised significant concerns about data privacy and regulatory oversight. After sending a small tube of saliva to uncover ancestral roots, many individuals discovered that their genetic data had been compromised. 23andMe has transformed genetic testing by offering accessible health and ancestry information to consumers from the comfort of their homes. Since its inception, the company has faced regulatory challenges and became the first direct-to-consumer genetic genealogy test to receive FDA approval. While the company has largely avoided legal trouble over the years, recent data breaches have sparked legal action and underscored gaps in consumer protection.
Got (Plant) Milk? The Rise and Regulation of the Alternative Meat and Dairy Markets
The plant-based food market has been exploding in recent years, with the plant-based meat market expected to reach a value of $7.4 billion by the end of 2022 and the alternative dairy market reaching a value of $23.2 billion in 2021.
The meat and dairy alternative markets require regulation, but despite their widespread and growing popularity, the U.S. Food and Drug Administration (FDA) has been slow to issue regulations that encompass these markets. In January 2022, the FDA released a list of draft and final guidance topics that it intends to complete before the end of 2022. These topics include draft guidance for plant-based dairy alternatives, plant-based meat alternatives, and for cultured meat. The FDA is soliciting public comments on the proposed guidance, although as of now none of the draft guidance topics have been released to the public